91 related articles for article (PubMed ID: 10401882)
1. Hormone replacement therapy and colon cancer among members of a health maintenance organization.
Jacobs EJ; White E; Weiss NS; Heckbert SR; LaCroix A; Barlow WE
Epidemiology; 1999 Jul; 10(4):445-51. PubMed ID: 10401882
[TBL] [Abstract][Full Text] [Related]
2. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Weiss NS; Larson EB; Rosendaal FR; Psaty BM
JAMA; 2004 Oct; 292(13):1581-7. PubMed ID: 15467060
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hormone use and risk of large-bowel cancer.
Newcomb PA; Storer BE
J Natl Cancer Inst; 1995 Jul; 87(14):1067-71. PubMed ID: 7616598
[TBL] [Abstract][Full Text] [Related]
4. Relationship of food groups and water intake to colon cancer risk.
Shannon J; White E; Shattuck AL; Potter JD
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):495-502. PubMed ID: 8827352
[TBL] [Abstract][Full Text] [Related]
5. Estrogens, progesterone, and endometrial cancer.
Jick SS; Walker AM; Jick H
Epidemiology; 1993 Jan; 4(1):20-4. PubMed ID: 8380547
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a formulary switch from conjugated to esterified estrogens in a managed care setting.
Andrade SE; Gurwitz JH; Cernieux J; Fish LS
Med Care; 2000 Sep; 38(9):970-5. PubMed ID: 10982118
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy in relation to survival in women diagnosed with colon cancer.
Mandelson MT; Miglioretti D; Newcomb PA; Harrison R; Potter JD
Cancer Causes Control; 2003 Dec; 14(10):979-84. PubMed ID: 14750537
[TBL] [Abstract][Full Text] [Related]
8. Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA).
Jacobs EJ; White E; Weiss NS
Cancer Causes Control; 1994 Jul; 5(4):359-66. PubMed ID: 8080948
[TBL] [Abstract][Full Text] [Related]
9. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Ross RK; Paganini-Hill A; Wan PC; Pike MC
J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
[TBL] [Abstract][Full Text] [Related]
10. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
[TBL] [Abstract][Full Text] [Related]
11. Constipation, laxative use, and colon cancer among middle-aged adults.
Jacobs EJ; White E
Epidemiology; 1998 Jul; 9(4):385-91. PubMed ID: 9647901
[TBL] [Abstract][Full Text] [Related]
12. Decline in incidence of endometrial cancer following increase in prescriptions for opposed conjugated estrogens in a prepaid health plan.
Ziel HK; Finkle WD; Greenland S
Gynecol Oncol; 1998 Mar; 68(3):253-5. PubMed ID: 9570976
[TBL] [Abstract][Full Text] [Related]
13. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
Ettinger B; Pressman A; Bradley C
Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
[TBL] [Abstract][Full Text] [Related]
14. Estrogen plus progestin and risk of venous thrombosis.
Cushman M; Kuller LH; Prentice R; Rodabough RJ; Psaty BM; Stafford RS; Sidney S; Rosendaal FR;
JAMA; 2004 Oct; 292(13):1573-80. PubMed ID: 15467059
[TBL] [Abstract][Full Text] [Related]
15. Risk of endometrial cancer in relation to use of low-dose, unopposed estrogens.
Cushing KL; Weiss NS; Voigt LF; McKnight B; Beresford SA
Obstet Gynecol; 1998 Jan; 91(1):35-9. PubMed ID: 9464717
[TBL] [Abstract][Full Text] [Related]
16. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.
Waters DD; Alderman EL; Hsia J; Howard BV; Cobb FR; Rogers WJ; Ouyang P; Thompson P; Tardif JC; Higginson L; Bittner V; Steffes M; Gordon DJ; Proschan M; Younes N; Verter JI
JAMA; 2002 Nov; 288(19):2432-40. PubMed ID: 12435256
[TBL] [Abstract][Full Text] [Related]
17. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
[TBL] [Abstract][Full Text] [Related]
18. Acceptability of a substitution of estrogen replacement therapy to women enrolled in a health maintenance organization.
Gardner J; Scholes D; Baluch W; Krauss R
J Womens Health; 1998 Oct; 7(8):1027-31. PubMed ID: 9812299
[TBL] [Abstract][Full Text] [Related]
19. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States).
Slattery ML; Ballard-Barbash R; Edwards S; Caan BJ; Potter JD
Cancer Causes Control; 2003 Feb; 14(1):75-84. PubMed ID: 12708728
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening.
Persson I; Thurfjell E; Bergstrom R; Holmberg L
Int J Cancer; 1997 Sep; 72(5):758-61. PubMed ID: 9311590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
